Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Barry

Showing results (531-540 of 674) with videos related to

Pageof 68
Sort By:
Leukemia|September 16, 2024
Potent combination benefit of the AKT inhibitor capivasertib and the BCL-2 inhibitor venetoclax in diffuse large B cell lymphomaBrandon S Willis, Kevin Mongeon, Hannah Dry, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 29, 2019
A phase II feasibility study of palbociclib in combination with adjuvant endocrine therapy for hormone receptor-positive invasive breast carcinomaE L Mayer, A DeMichele, H S Rugo, et al.
Sleep & Breathing = Schlaf & Atmung|June 20, 2020
Correlates of sleep quality and excessive daytime sleepiness in people with opioid use disorder receiving methadone treatmentStephen R Baldassarri, Mark Beitel, Andrey Zinchuk, et al.
Journal of the National Cancer Institute|June 27, 2015
Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741 (Alliance)Jennifer A Ligibel, Constance T Cirrincione, Minetta Liu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 27, 2015
Long-term Prescription of Opioids and/or Benzodiazepines and Mortality Among HIV-Infected and Uninfected PatientsDaniel F Weisberg, Kirsha S Gordon, Declan T Barry, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|June 3, 2022
Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of cardiovascular complications in patients with post-acute sequelae of SARS-CoV-2 infection (PASC)Jonathan H Whiteson, Alba Azola, John T Barry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2009
A genomic approach to improve prognosis and predict therapeutic response in chronic lymphocytic leukemiaDaphne R Friedman, J Brice Weinberg, William T Barry, et al.
Analytical Chemistry|June 11, 2020
Universal Sample Preparation Unlocking Multimodal Molecular Tissue ImagingAndreas Dannhorn, Emine Kazanc, Stephanie Ling, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 25, 2025
Virtual Histological Staining as a Tool for Extending Renal Segmentation Across StainsJames Denholm, Azam Hamidinekoo, Nikolay Burlutskiy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2016
Phase III Trial Evaluating Letrozole As First-Line Endocrine Therapy With or Without Bevacizumab for the Treatment of Postmenopausal Women With Hormone Receptor-Positive Advanced-Stage Breast Cancer: CALGB 40503 (Alliance)Maura N Dickler, William T Barry, Constance T Cirrincione, et al.
Pageof 68

Showing results (531-540 of 674) with videos related to

Sort By:
Pageof 68
Leukemia|September 16, 2024
Potent combination benefit of the AKT inhibitor capivasertib and the BCL-2 inhibitor venetoclax in diffuse large B cell lymphomaBrandon S Willis, Kevin Mongeon, Hannah Dry, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 29, 2019
A phase II feasibility study of palbociclib in combination with adjuvant endocrine therapy for hormone receptor-positive invasive breast carcinomaE L Mayer, A DeMichele, H S Rugo, et al.
Sleep & Breathing = Schlaf & Atmung|June 20, 2020
Correlates of sleep quality and excessive daytime sleepiness in people with opioid use disorder receiving methadone treatmentStephen R Baldassarri, Mark Beitel, Andrey Zinchuk, et al.
Journal of the National Cancer Institute|June 27, 2015
Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741 (Alliance)Jennifer A Ligibel, Constance T Cirrincione, Minetta Liu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 27, 2015
Long-term Prescription of Opioids and/or Benzodiazepines and Mortality Among HIV-Infected and Uninfected PatientsDaniel F Weisberg, Kirsha S Gordon, Declan T Barry, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|June 3, 2022
Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of cardiovascular complications in patients with post-acute sequelae of SARS-CoV-2 infection (PASC)Jonathan H Whiteson, Alba Azola, John T Barry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2009
A genomic approach to improve prognosis and predict therapeutic response in chronic lymphocytic leukemiaDaphne R Friedman, J Brice Weinberg, William T Barry, et al.
Analytical Chemistry|June 11, 2020
Universal Sample Preparation Unlocking Multimodal Molecular Tissue ImagingAndreas Dannhorn, Emine Kazanc, Stephanie Ling, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 25, 2025
Virtual Histological Staining as a Tool for Extending Renal Segmentation Across StainsJames Denholm, Azam Hamidinekoo, Nikolay Burlutskiy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2016
Phase III Trial Evaluating Letrozole As First-Line Endocrine Therapy With or Without Bevacizumab for the Treatment of Postmenopausal Women With Hormone Receptor-Positive Advanced-Stage Breast Cancer: CALGB 40503 (Alliance)Maura N Dickler, William T Barry, Constance T Cirrincione, et al.
Pageof 68